Skip to content
healthcare.dev

Ranolazine

NDC 27241-125, Ranolazine, tablet, extended release, from Ajanta Pharma USA Inc..

Product NDC
27241-125
Status
Listed
Labeler
Ajanta Pharma USA Inc.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA210054
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/27241-125 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RANOLAZINE500 mg/1

Pharmacologic classes

Anti-anginal [EPC]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; Organic Cation Transporter 2 Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]

Package NDCNDC-11Package
27241-125-022724101250260 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-125-02)
27241-125-0527241012505500 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-125-05)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/8bfd1a61-547a-4847-ae4e-480b17da6272
  • NADAC price for package 27241012502

    GET /v1/drugs/nadac/27241012502
  • NADAC price for package 27241012505

    GET /v1/drugs/nadac/27241012505

Use it

Look up 27241-125 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/27241-125 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 27241-125. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.